| NCT03578367 |
Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) |
https://ClinicalTrials.gov/show/NCT03578367 |
Recruiting |
Novartis |
2021-11-23 |
| NCT03394755 |
Thrombosomes® in Bleeding Thrombocytopenic Patients |
https://ClinicalTrials.gov/show/NCT03394755 |
Active, not recruiting |
Cellphire, Inc. |
2019-08-03 |
| NCT03367546 |
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases |
https://ClinicalTrials.gov/show/NCT03367546 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2025-11-30 |
| NCT03870750 |
Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases |
https://ClinicalTrials.gov/show/NCT03870750 |
Recruiting |
Fred Hutchinson Cancer Research Center |
2024-06-30 |
| NCT03355742 |
XIENCE 28 Global Study |
https://ClinicalTrials.gov/show/NCT03355742 |
Completed |
Abbott Medical Devices |
2019-10-24 |
| NCT03343834 |
Methyl-qPCR : a New Predictive Marker for Epstein-Barr Virus-associated Lymphoproliferations During Allogeneic Hematopoietic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT03343834 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-01-31 |
| NCT03342495 |
Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial |
https://ClinicalTrials.gov/show/NCT03342495 |
Recruiting |
University of Calgary |
2019-12-31 |
| NCT03272789 |
Onco-coaching of Sport-inspired for the Social, Professional and Psychological Restoring of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells |
https://ClinicalTrials.gov/show/NCT03272789 |
Recruiting |
Institut Paoli-Calmettes |
2019-07-31 |
| NCT03093844 |
Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT03093844 |
Active, not recruiting |
University of Colorado, Denver |
2022-02-10 |
| NCT03079089 |
Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders |
https://ClinicalTrials.gov/show/NCT03079089 |
Recruiting |
Association for Training, Education, and Research in Hematology, Immunology, and Transplantation |
2020-06-15 |
| NCT03066648 |
Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS |
https://ClinicalTrials.gov/show/NCT03066648 |
Recruiting |
Novartis |
2021-11-01 |
| NCT03048344 |
A Phase I, Two-part Study to Determine the Recommended Dose and Evaluate the Safety and Tolerability of a Novel Oral Arsenic Trioxide Formulation (ORH-2014) in Subjects With Advanced Hematological Disorders |
https://ClinicalTrials.gov/show/NCT03048344 |
Completed |
Orsenix LLC |
2019-02-28 |
| NCT03030248 |
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients |
https://ClinicalTrials.gov/show/NCT03030248 |
Recruiting |
Medical College of Wisconsin |
2020-06-30 |
| NCT03016806 |
Umbilical Cord Blood Transplantation From Unrelated Donors |
https://ClinicalTrials.gov/show/NCT03016806 |
Recruiting |
University of Rochester |
2025-06-30 |
| NCT03013439 |
Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) |
https://ClinicalTrials.gov/show/NCT03013439 |
Completed |
Pharmacosmos A/S |
2017-06-04 |
| NCT03004261 |
CMV-CTL for the Treatment of CMV Infection After HSCT |
https://ClinicalTrials.gov/show/NCT03004261 |
Recruiting |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2020-12-31 |
| NCT02882776 |
Daily Ginger Drinking and Platelet Function |
https://ClinicalTrials.gov/show/NCT02882776 |
Completed |
King Abdullah International Medical Research Center |
2016-07-31 |
| NCT02722668 |
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep |
https://ClinicalTrials.gov/show/NCT02722668 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2028-05-31 |
| NCT02678910 |
Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis/Treatment |
https://ClinicalTrials.gov/show/NCT02678910 |
Recruiting |
University of Kentucky |
2021-01-31 |
| NCT02661035 |
Allo HSCT Using RIC for Hematological Diseases |
https://ClinicalTrials.gov/show/NCT02661035 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2023-03-31 |
| NCT02660281 |
URMC Related Haplo-identical Donor BMT |
https://ClinicalTrials.gov/show/NCT02660281 |
Recruiting |
University of Rochester |
2025-10-31 |
| NCT01524536 |
Steroid Treatment for Hypereosinophilic Syndrome |
https://ClinicalTrials.gov/show/NCT01524536 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2024-12-31 |
| NCT02494258 |
A Study to Evaluate Long-term Safety in Subjects With Solid Tumors and Hematological Disorders. |
https://ClinicalTrials.gov/show/NCT02494258 |
Active, not recruiting |
Celgene |
2021-02-28 |
| NCT02487563 |
Prospective Study of Patients With Thrombocytopenia Following HSCT |
https://ClinicalTrials.gov/show/NCT02487563 |
Completed |
The First Affiliated Hospital of Soochow University |
2019-04-12 |
| NCT02484053 |
Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders |
https://ClinicalTrials.gov/show/NCT02484053 |
Completed |
Baylor College of Medicine |
2017-01-31 |
| NCT02483325 |
Study Evaluating the Efficacy of Allogeneic Transplant Conditioning With Adaptive Dose Busulfan Intravenous (Busilvex®) in Patients at High Risk of Carrying Blood Diseases |
https://ClinicalTrials.gov/show/NCT02483325 |
Completed |
Institut Paoli-Calmettes |
2018-03-31 |
| NCT02447237 |
Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic Patients |
https://ClinicalTrials.gov/show/NCT02447237 |
Completed |
University of Copenhagen |
2015-07-31 |
| NCT02435316 |
Comparison of Educational Methods for Teaching Peripheral Blood Smears |
https://ClinicalTrials.gov/show/NCT02435316 |
Completed |
The Reading Hospital and Medical Center |
2012-06-30 |
| NCT02343965 |
The Impact of the Practice of Touch-massage on the Anxiety of Patients With Hematological Disorders Hospitalized in a Protective Environment, a Randomized, Controlled Study |
https://ClinicalTrials.gov/show/NCT02343965 |
Completed |
Nantes University Hospital |
2015-12-31 |
| NCT02218151 |
Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2 |
https://ClinicalTrials.gov/show/NCT02218151 |
Recruiting |
Duke University |
2021-08-31 |
| NCT02179359 |
Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies |
https://ClinicalTrials.gov/show/NCT02179359 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2020-08-31 |
| NCT02158052 |
Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease |
https://ClinicalTrials.gov/show/NCT02158052 |
Recruiting |
Massachusetts General Hospital |
2021-02-28 |
| NCT02130882 |
Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome |
https://ClinicalTrials.gov/show/NCT02130882 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2022-12-31 |
| NCT02095951 |
Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection |
https://ClinicalTrials.gov/show/NCT02095951 |
Completed |
Children’s Hospital of Michigan |
2016-06-30 |
| NCT01962636 |
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases |
https://ClinicalTrials.gov/show/NCT01962636 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2023-10-31 |
| NCT01959100 |
Efficacy of Azithromycin to Prevent Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT01959100 |
Active, not recruiting |
Assistance Publique - Hôpitaux de Paris |
2017-04-30 |
| NCT01844765 |
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. |
https://ClinicalTrials.gov/show/NCT01844765 |
Active, not recruiting |
Novartis |
2016-06-01 |
| NCT01790568 |
Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT01790568 |
Completed |
University of Michigan Rogel Cancer Center |
2017-01-01 |
| NCT01787552 |
A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF |
https://ClinicalTrials.gov/show/NCT01787552 |
Completed |
Novartis |
2018-04-10 |
| NCT01670097 |
Dexamethasone Dyspnea Study |
https://ClinicalTrials.gov/show/NCT01670097 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2021-01-31 |
| NCT01666080 |
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) |
https://ClinicalTrials.gov/show/NCT01666080 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2020-06-30 |
| NCT01602952 |
Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI |
https://ClinicalTrials.gov/show/NCT01602952 |
Completed |
Il-Yang Pharm. Co., Ltd. |
2012-10-31 |
| NCT01553461 |
Transplants With Unlicensed Preserved Cord Blood |
https://ClinicalTrials.gov/show/NCT01553461 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2036-10-20 |
| NCT01511289 |
Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients |
https://ClinicalTrials.gov/show/NCT01511289 |
Completed |
Il-Yang Pharm. Co., Ltd. |
2015-02-28 |
| NCT01445561 |
Ultra Low Dose Interleukin-2 in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01445561 |
Completed |
National Institutes of Health Clinical Center (CC) |
2013-07-15 |
| NCT01426295 |
Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital |
https://ClinicalTrials.gov/show/NCT01426295 |
Completed |
Nantes University Hospital |
2013-04-30 |
| NCT01352520 |
SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) |
https://ClinicalTrials.gov/show/NCT01352520 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2021-01-31 |
| NCT01344681 |
Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases |
https://ClinicalTrials.gov/show/NCT01344681 |
Completed |
Yonsei University |
2014-03-31 |
| NCT04353986 |
PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders |
https://ClinicalTrials.gov/show/NCT04353986 |
Recruiting |
Ain Shams University |
2020-04-30 |
| NCT04310592 |
Natural Killer Cell (CYNK-001) Infusions in Adults With AML |
https://ClinicalTrials.gov/show/NCT04310592 |
Recruiting |
Celularity Incorporated |
2022-01-03 |
| NCT04309084 |
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma |
https://ClinicalTrials.gov/show/NCT04309084 |
Recruiting |
Celularity Incorporated |
2023-03-12 |
| NCT04249830 |
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults |
https://ClinicalTrials.gov/show/NCT04249830 |
Recruiting |
Stanford University |
2025-02-28 |
| NCT04208243 |
Creative Arts Therapy (CAT) in the Center for Cancer and Blood Disorders |
https://ClinicalTrials.gov/show/NCT04208243 |
Recruiting |
University of Colorado, Denver |
2021-02-28 |
| NCT04202094 |
Evaluation of Fertility in Young Adults Who Did or Did Not Store Testicular Tissue Before a Treatment Possibly Leading to Later Fertility Problems. |
https://ClinicalTrials.gov/show/NCT04202094 |
Recruiting |
Universitair Ziekenhuis Brussel |
2022-12-31 |
| NCT04180059 |
Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT04180059 |
Recruiting |
Nantes University Hospital |
2022-09-30 |
| NCT04168983 |
Impact of Sophrology on the Pain Felt During a Bone Marrow Aspiration and Biopsy |
https://ClinicalTrials.gov/show/NCT04168983 |
Recruiting |
University Hospital, Caen |
2021-09-25 |
| NCT04062266 |
Azacitidine and Venetoclax in Treating Patients With High Risk Acute Myeloid Leukemia in Remission |
https://ClinicalTrials.gov/show/NCT04062266 |
Recruiting |
M.D. Anderson Cancer Center |
2030-10-31 |
| NCT04039100 |
Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease |
https://ClinicalTrials.gov/show/NCT04039100 |
Recruiting |
Rigshospitalet, Denmark |
2021-02-01 |
| NCT03959007 |
Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases |
https://ClinicalTrials.gov/show/NCT03959007 |
Recruiting |
University Hospital, Lille |
2021-09-30 |
| NCT03918343 |
Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT03918343 |
Recruiting |
Centre Hospitalier Universitaire de Besancon |
2021-11-30 |
| NCT03895918 |
Parenting Skills Intervention in Improving Medication Adherence in Pediatric Cancer Patients |
https://ClinicalTrials.gov/show/NCT03895918 |
Recruiting |
Roswell Park Cancer Institute |
2020-07-27 |
| NCT03875352 |
The Influence of Nursing Technique Applied at the Central Venous Catheter Insertion Site Upon the Incidence of Infection |
https://ClinicalTrials.gov/show/NCT03875352 |
Completed |
University Hospital Ostrava |
2018-12-31 |
| NCT03842696 |
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation |
https://ClinicalTrials.gov/show/NCT03842696 |
Recruiting |
University of Michigan Rogel Cancer Center |
2024-02-29 |
| NCT03815175 |
XIENCE 28 USA Study |
https://ClinicalTrials.gov/show/NCT03815175 |
Active, not recruiting |
Abbott Medical Devices |
2020-12-31 |
| NCT03803696 |
Multimodal Sexual Dysfunction Intervention In HCT |
https://ClinicalTrials.gov/show/NCT03803696 |
Recruiting |
Massachusetts General Hospital |
2024-01-01 |
| NCT03778606 |
Oligosaccharide for Cdiff(+) Heme-onc Patients |
https://ClinicalTrials.gov/show/NCT03778606 |
Recruiting |
Medical College of Wisconsin |
2020-06-01 |
| NCT03745287 |
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease |
https://ClinicalTrials.gov/show/NCT03745287 |
Recruiting |
Vertex Pharmaceuticals Incorporated |
2021-02-28 |
| NCT03735992 |
Mind-body Medicine for Patients With Malignant Hematological Diseases |
https://ClinicalTrials.gov/show/NCT03735992 |
Recruiting |
Universität Duisburg-Essen |
2020-12-30 |
| NCT03734588 |
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors |
https://ClinicalTrials.gov/show/NCT03734588 |
Active, not recruiting |
Spark Therapeutics |
2020-05-31 |
| NCT03719534 |
Haplo SCT vs Haplo-cord SCT for Patients With Hematological Disorders |
https://ClinicalTrials.gov/show/NCT03719534 |
Recruiting |
The First Affiliated Hospital of Soochow University |
2020-12-31 |
| NCT03655678 |
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Transfusion-Dependent β-Thalassemia |
https://ClinicalTrials.gov/show/NCT03655678 |
Recruiting |
Vertex Pharmaceuticals Incorporated |
2021-02-28 |
| NCT03615144 |
TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors |
https://ClinicalTrials.gov/show/NCT03615144 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-07-31 |
| NCT03611257 |
Effect of dRAST on Treatment for Bacteremia in Patients With Hematologic Diseases |
https://ClinicalTrials.gov/show/NCT03611257 |
Completed |
Seoul National University Hospital |
2019-09-15 |
| NCT03548766 |
Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping |
https://ClinicalTrials.gov/show/NCT03548766 |
Recruiting |
Hamad Medical Corporation |
2019-12-31 |
| NCT03520712 |
Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5 |
https://ClinicalTrials.gov/show/NCT03520712 |
Enrolling by invitation |
BioMarin Pharmaceutical |
2025-06-30 |
| NCT03518294 |
NASH Fitness Intervention in Thrombosis Trial (NASHFit) |
https://ClinicalTrials.gov/show/NCT03518294 |
Recruiting |
Milton S. Hershey Medical Center |
2021-06-01 |
| NCT03426553 |
Clinical Use of Pathogen Reduced Red Blood Cell Suspension |
https://ClinicalTrials.gov/show/NCT03426553 |
Completed |
Federal Research Institute of Pediatric Hematology, Oncology and Immunology |
2018-09-17 |
| NCT01224496 |
Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological Disorders |
https://ClinicalTrials.gov/show/NCT01224496 |
Completed |
Singapore General Hospital |
2011-08-31 |
| NCT01220011 |
Randomized Controlled Trial Comparing a Conservative Management and Laser Surgery |
https://ClinicalTrials.gov/show/NCT01220011 |
Active, not recruiting |
Assistance Publique - Hôpitaux de Paris |
2018-09-30 |
| NCT01210716 |
Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device |
https://ClinicalTrials.gov/show/NCT01210716 |
Completed |
Fenwal, Inc. |
2011-05-31 |
| NCT00994136 |
Safety of Catheter Lock With or Without Heparin in Implanted Central Venous Catheters |
https://ClinicalTrials.gov/show/NCT00994136 |
Completed |
Universitaire Ziekenhuizen Leuven |
2011-06-30 |
| NCT00993486 |
Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor |
https://ClinicalTrials.gov/show/NCT00993486 |
Completed |
Kiadis Pharma |
2008-10-31 |
| NCT00954941 |
Ondansetron Versus Aprepitant Plus Ondansetron for Emesis |
https://ClinicalTrials.gov/show/NCT00954941 |
Completed |
M.D. Anderson Cancer Center |
2013-04-30 |
| NCT00919503 |
Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders |
https://ClinicalTrials.gov/show/NCT00919503 |
Recruiting |
Fred Hutchinson Cancer Research Center |
2023-02-01 |
| NCT00897260 |
Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00897260 |
Completed |
University of British Columbia |
2013-01-09 |
| NCT00892502 |
Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? |
https://ClinicalTrials.gov/show/NCT00892502 |
Completed |
Copenhagen University Hospital at Herlev |
2012-01-31 |
| NCT03886909 |
Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow Transplant |
https://ClinicalTrials.gov/show/NCT03886909 |
Recruiting |
Milton S. Hershey Medical Center |
2021-05-31 |
| NCT01974401 |
Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood Dyscrasia |
https://ClinicalTrials.gov/show/NCT01974401 |
Completed |
Mashhad University of Medical Sciences |
2011-03-31 |
| NCT03547609 |
Assessment of Memory in Children With Kabuki Syndrom |
https://ClinicalTrials.gov/show/NCT03547609 |
Completed |
University Hospital, Montpellier |
2018-09-07 |
| NCT02632708 |
Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation |
https://ClinicalTrials.gov/show/NCT02632708 |
Active, not recruiting |
Agios Pharmaceuticals, Inc. |
2018-12-13 |
| NCT00800839 |
Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide |
https://ClinicalTrials.gov/show/NCT00800839 |
Completed |
M.D. Anderson Cancer Center |
2015-07-31 |
| NCT00636909 |
Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00636909 |
Completed |
Beth Israel Deaconess Medical Center |
2006-03-31 |
| NCT00616460 |
ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for Bleeding |
https://ClinicalTrials.gov/show/NCT00616460 |
Completed |
HaEmek Medical Center, Israel |
2011-10-31 |
| NCT00586521 |
BAY14-2222 Prophylaxis and Joint Function Improvement (Adults) |
https://ClinicalTrials.gov/show/NCT00586521 |
Completed |
Bayer |
2008-03-31 |
| NCT00582894 |
Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases |
https://ClinicalTrials.gov/show/NCT00582894 |
Completed |
University of Oklahoma |
2008-03-31 |
| NCT00533923 |
Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00533923 |
Completed |
Beth Israel Deaconess Medical Center |
2007-01-31 |
| NCT00507533 |
Early Application of CPAP in Hematologic |
https://ClinicalTrials.gov/show/NCT00507533 |
Completed |
University of Turin, Italy |
2007-11-30 |
| NCT00484848 |
Functional Evaluation of Two Types of Totally Implanted Venous Ports |
https://ClinicalTrials.gov/show/NCT00484848 |
Completed |
Universitaire Ziekenhuizen Leuven |
2004-12-31 |
| NCT00309842 |
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases |
https://ClinicalTrials.gov/show/NCT00309842 |
Completed |
Masonic Cancer Center, University of Minnesota |
2019-07-29 |
| NCT00231309 |
Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT) |
https://ClinicalTrials.gov/show/NCT00231309 |
Completed |
Emory University |
2011-11-30 |
| NCT00213239 |
A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children |
https://ClinicalTrials.gov/show/NCT00213239 |
Completed |
The Hospital for Sick Children |
2007-09-30 |
| NCT00208962 |
Allogeneic Cell Therapy for Adults With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT00208962 |
Completed |
Emory University |
2007-09-30 |
| NCT00168090 |
Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) |
https://ClinicalTrials.gov/show/NCT00168090 |
Completed |
CSL Behring |
NA |
| NCT00137787 |
Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases |
https://ClinicalTrials.gov/show/NCT00137787 |
Completed |
Center for Supporting Hematology-Oncology Trials |
2009-12-31 |
| NCT00113893 |
SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes. |
https://ClinicalTrials.gov/show/NCT00113893 |
Completed |
Scios, Inc. |
2007-12-31 |
| NCT00111215 |
Treatment and Management of Women With Bleeding Disorders |
https://ClinicalTrials.gov/show/NCT00111215 |
Completed |
Centers for Disease Control and Prevention |
NA |
| NCT01114165 |
Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients |
https://ClinicalTrials.gov/show/NCT01114165 |
Completed |
University Hospital Muenster |
2012-09-30 |
| NCT00071032 |
Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease |
https://ClinicalTrials.gov/show/NCT00071032 |
Completed |
Rutgers, The State University of New Jersey |
2009-05-31 |
| NCT00056966 |
Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases |
https://ClinicalTrials.gov/show/NCT00056966 |
Completed |
Baylor College of Medicine |
2005-05-31 |
| NCT00001839 |
A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00001839 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001338 |
A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer |
https://ClinicalTrials.gov/show/NCT00001338 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00029393 |
Induction of Stable Chimerism for Sickle Cell Anemia |
https://ClinicalTrials.gov/show/NCT00029393 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
2007-07-31 |
| NCT00029380 |
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia |
https://ClinicalTrials.gov/show/NCT00029380 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
2006-08-31 |
| NCT00023530 |
Blood and Marrow Transplant Clinical Research Network |
https://ClinicalTrials.gov/show/NCT00023530 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00820508 |
Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies |
https://ClinicalTrials.gov/show/NCT00820508 |
Completed |
Chroma Therapeutics |
2011-07-31 |
| NCT00006400 |
Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia |
https://ClinicalTrials.gov/show/NCT00006400 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
2009-09-30 |
| NCT00006182 |
Stroke Prevention in Sickle Cell Anemia (STOP 2) |
https://ClinicalTrials.gov/show/NCT00006182 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00001749 |
Medical Treatment for Diamond Blackfan Anemia |
https://ClinicalTrials.gov/show/NCT00001749 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00000603 |
Cord Blood Stem Cell Transplantation Study (COBLT) |
https://ClinicalTrials.gov/show/NCT00000603 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
2007-10-31 |
| NCT00000602 |
Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG) |
https://ClinicalTrials.gov/show/NCT00000602 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00000597 |
Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00000597 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00000595 |
Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis |
https://ClinicalTrials.gov/show/NCT00000595 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00000592 |
Stroke Prevention in Sickle Cell Anemia (STOP 1) |
https://ClinicalTrials.gov/show/NCT00000592 |
Completed |
Augusta University |
NA |
| NCT00000589 |
Trial to Reduce Alloimmunization to Platelets (TRAP) |
https://ClinicalTrials.gov/show/NCT00000589 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00000588 |
Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone |
https://ClinicalTrials.gov/show/NCT00000588 |
Completed |
Case Western Reserve University |
NA |
| NCT00000587 |
Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection |
https://ClinicalTrials.gov/show/NCT00000587 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00000586 |
Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH) |
https://ClinicalTrials.gov/show/NCT00000586 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
1994-06-30 |
| NCT00000585 |
Penicillin Prophylaxis in Sickle Cell Disease (PROPS) |
https://ClinicalTrials.gov/show/NCT00000585 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00000582 |
Cooperative Study of Factor VIII Inhibitors |
https://ClinicalTrials.gov/show/NCT00000582 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |